Percentage change in COVID-19 laCFR given a 1 unit increase in the variable for each individual variable (shown in black dots) and 95% confidence interval (shown in red), using tra... by Jess A. Millar (2635135)

Subjects:

The combination of LPS and PFC caused faster clot initiation and decreased clot strength. by Heather F. Pidcoke (9023789)

Leptin receptor deficiency caused decrease in cortical bone mainly in female mice. by Devorah M. Natelson (8807576)

S1 Graphical - by Agnieszka Murawska (11021928)

Subjects:

Non-enzymatic antioxidants in hemolymph of honey bee workers. by Agnieszka Murawska (11021928)

Subjects:

Concentration of active substances found in pollen, nectar or honey and concentration used in the study. by Agnieszka Murawska (11021928)

Subjects:

Enzymes activity in hemolymph of honey bee workers. by Agnieszka Murawska (11021928)

Subjects:

Groupings of statistically significantly associated proteins by their biological processes. by Alish B. Palmos (5857379)

Kaplan–Meier curves for all-cause mortality. by Arisa Kobayashi (4379608)

“…Notably, the denosumab group showed a significant decrease in mortality, particularly in cardiovascular disease-related cases (HR, 0.33 [95% CI, 0.14–0.78]).…”

Discontinuous DEX PK raw data from repeated study. by Kavya Annu (11587215)

Subjects:

Kaplan-Meier curves for the effect of VD₃ sufficiency vs. deficiency on survival of mice from BCR-ABL Arf-/- leukemia. by Kavya Annu (11587215)

Subjects:

Plasma DEX concentrations in C57BL/6 VD₃ sufficient and deficient mice on a discontinuous DEX regimen. by Kavya Annu (11587215)

Subjects:

Serum 25(OH)VD3 levels in VD₃ sufficient and deficient mice. by Kavya Annu (11587215)

Subjects:

Cartoon depicting dexamethasone and dasatinib metabolism and efflux transport in intestine and liver. by Kavya Annu (11587215)

Subjects:

Differences in plasma and gut dexamethasone concentrations following the oral discontinuous DEX regimen leads to tissue specific activation of GCR and PXR. by Kavya Annu (11587215)

Subjects:

Gene expression (qPCR) data from livers of C57BL/6 mice before and after DEX treatment. by Kavya Annu (11587215)

Subjects:

Cyp and transporter gene expression in duodenum of VD₃ sufficient and deficient mice. by Kavya Annu (11587215)

Subjects:

Raw data from survival study in VD₃ sufficient vs. deficient male mice from BCR-ABL ALL when treated with dexamethasone. by Kavya Annu (11587215)

Subjects:

Dexamethasone plasma pharmacokinetics in male and female VD₃ sufficient and deficient mice, aged 14 weeks, after a single oral gavage of 2 mg/kg dexamethasone phosphate. by Kavya Annu (11587215)

Subjects:

Cyp and transporter gene expression in liver and kidney of 12-week-old hCYP3A4 mice. by Kavya Annu (11587215)

Subjects: